Dr Sara B Seidelmann

Following undergraduate education at Cornell University, she completed a Master of Science in Human Nutrition and Master of Arts, Master of Philosophy and Ph.D. in Nutritional and Metabolic Biology from Columbia University and the Institute of Human Nutrition, graduating with distinction.  She completed post-graduate and medical training at the Cleveland Clinic Foundation and Case Western Medical School.  From medical school, she was accepted into the prestigious Physician Scientist Training Program at Yale School of Medicine and Yale New Haven Hospital where she finished her internship and residency training in Internal Medicine and clinical fellowship training in Cardiovascular Medicine.  She went on to Harvard Medical School, Harvard School of Public Health and Brigham & Women’s Hospital, completing research and clinical training supported by the National Institutes of Health.

Dr. Seidelmann’s research has focused on understanding the complex inter-relationship between genes, pathogens, nutrients, cardiovascular health, and aging. During her tenure in the Brigham & Women’s Cardiac Imaging Core Lab, she worked on the quantitative assessment of cardiac structure and function in clinical trials and epidemiologic studies in the Atherosclerosis Rick in Communities cohort (ARIC), Hispanic Community Health Study/Study of Latinos (SOL) cohort, Sarcomeric Human Cardiomyopathy Registry (SHARE), Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) trial, and Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial as well as Brigham & Women’s and Massachusetts General Hospital based cohorts. Her original research has been published in top-tier medical journals such as the Journal of the American College of Cardiology, Circulation, European Heart Journal, The Proceedings of the National Academy of Sciences, Lancet Public Health and Lancet Diabetes and Endocrinology.

Some notable work includes her genetic research on the sodium-glucose transporter, SGLT1, which spurred two clinical trials of the SGLT1/SGLT2 inhibitor, Sotagliflozin. SOLOIST-WHF and SCORED, both published in the New England Journal of Medicine in 2021, showing dramatic reduction of death and heart failure in those receiving the drug versus placebo. 

She was the Principal Investigator of the Study of Lifestyle and Covid-19 Risk in Physicians and Nurses, designed early in the Covid-19 pandemic, collaborating with a team of researchers from Columbia, John’s Hopkins, Harvard, and Cedar Sinai to assess the association between lifestyle choices, such as nutrition and sleep, with COVID-19 outcomes in frontline healthcare workers from the U.S. and five European countries. 

Overall, her expertise has been the feature of over 600 news articles and covered by media outlets worldwide.  These include: Forbes, USA Today, Wall Street Journal, Time Magazine, The Today Show, NPR, CNN, CNBC, US News & World Report, NY Times, Newsweek, People, Prevention, Shape, Fitness, Elle, Cosmo, Esquire, Men’s Health, Reader’s Digest, London Evening Standard, BBC, BBC World, The Guardian, The Japan Times, The Sydney Morning Herald, In Style Australia, The Irish Times, The New Zealand Herald, The South African, Highfit (Brazil), Saude (Brazil), Metro Netherlands, Xinhua, South China Morning Post, Taipei Times, Vogue India, Hindustan Times (India), The Bangkok Post, Naked Science (Russia), Medportal (Russia), and the Canadian National Post.  Internationally, she has been an invited speaker in forums as diverse as The Karolinska Institute in Stockholm, The Danish Parliament Building, the National Institutes of Health (US), Russian and Japanese National TV, and BBC World (UK).  

Academically, Dr. Seidelmann has been involved in creating medical curriculum, teaching medical students, and mentoring residents and fellows at Columbia, Yale, and Harvard Medical Schools as well as authored core medical text. She is currently an Assistant Professor of Clinical Medicine at Columbia University Medical Center. 

Clinically, as a cardiovascular medicine physician, she has a breadth of experience covering emergency rooms, cardiac, medical and cardiothoracic ICUs, performing cardiovascular imaging, and assessing complex physiology.  Her clinical passions are in cardiometabolic disease, preventive cardiology, weight loss and personalized medicine. 

Personally, Dr. Seidelmann is a third generation, Greenwich, CT native. She finds great happiness in raising her family surrounded by her vast, extended family, and dear friends, and serving a community that she cares deeply for.